These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 20371229

  • 1. Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition.
    Marek GJ.
    Eur J Pharmacol; 2010 Aug 10; 639(1-3):81-90. PubMed ID: 20371229
    [Abstract] [Full Text] [Related]

  • 2. The difference in effect of mGlu2/3 and mGlu5 receptor agonists on cognitive impairment induced by MK-801.
    Vales K, Svoboda J, Benkovicova K, Bubenikova-Valesova V, Stuchlik A.
    Eur J Pharmacol; 2010 Aug 10; 639(1-3):91-8. PubMed ID: 20371226
    [Abstract] [Full Text] [Related]

  • 3. Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia.
    Chaki S.
    Eur J Pharmacol; 2010 Aug 10; 639(1-3):59-66. PubMed ID: 20371240
    [Abstract] [Full Text] [Related]

  • 4. Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia.
    Fell MJ, McKinzie DL, Monn JA, Svensson KA.
    Neuropharmacology; 2012 Mar 10; 62(3):1473-83. PubMed ID: 21704048
    [Abstract] [Full Text] [Related]

  • 5. Metabotropic glutamate receptor 7: at the interface of cognition and emotion.
    O'Connor RM, Finger BC, Flor PJ, Cryan JF.
    Eur J Pharmacol; 2010 Aug 10; 639(1-3):123-31. PubMed ID: 20371242
    [Abstract] [Full Text] [Related]

  • 6. In vitro characterisation of the novel positive allosteric modulators of the mGlu₅ receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat.
    Gilmour G, Broad LM, Wafford KA, Britton T, Colvin EM, Fivush A, Gastambide F, Getman B, Heinz BA, McCarthy AP, Prieto L, Shanks E, Smith JW, Taboada L, Edgar DM, Tricklebank MD.
    Neuropharmacology; 2013 Jan 10; 64():224-39. PubMed ID: 22884720
    [Abstract] [Full Text] [Related]

  • 7. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists.
    Mistry R, Golding N, Challiss RA.
    Br J Pharmacol; 1998 Feb 10; 123(3):581-9. PubMed ID: 9504400
    [Abstract] [Full Text] [Related]

  • 8. Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness.
    Lesage A, Steckler T.
    Eur J Pharmacol; 2010 Aug 10; 639(1-3):2-16. PubMed ID: 20371230
    [Abstract] [Full Text] [Related]

  • 9. [Targeting metabotropic glutamate receptors to develop novel antipsychotics].
    Chaki S, Yoshida S, Okuyama S.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Nov 10; 30(5-6):207-13. PubMed ID: 21226317
    [Abstract] [Full Text] [Related]

  • 10. Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats.
    Homayoun H, Jackson ME, Moghaddam B.
    J Neurophysiol; 2005 Apr 10; 93(4):1989-2001. PubMed ID: 15590730
    [Abstract] [Full Text] [Related]

  • 11. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.
    Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C, Akil M, Crook J, Vakkalanka RK, Balkissoon R, Gibbs RA, Kleinman JE, Weinberger DR.
    Proc Natl Acad Sci U S A; 2004 Aug 24; 101(34):12604-9. PubMed ID: 15310849
    [Abstract] [Full Text] [Related]

  • 12. mGlu1 potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficits.
    Maksymetz J, Byun NE, Luessen DJ, Li B, Barry RL, Gore JC, Niswender CM, Lindsley CW, Joffe ME, Conn PJ.
    Cell Rep; 2021 Nov 02; 37(5):109950. PubMed ID: 34731619
    [Abstract] [Full Text] [Related]

  • 13. [Metabotropic glutamate receptors as targets for new drug development].
    Arkhipov VI, Kapralova MV.
    Eksp Klin Farmakol; 2011 Nov 02; 74(10):46-52. PubMed ID: 22238988
    [Abstract] [Full Text] [Related]

  • 14. Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.
    Maksymetz J, Moran SP, Conn PJ.
    Mol Brain; 2017 Apr 26; 10(1):15. PubMed ID: 28446243
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological effects of metabotropic glutamate receptor ligands on prepulse inhibition in DBA/2J mice.
    Hikichi H, Nishino M, Fukushima M, Satow A, Maehara S, Kawamoto H, Ohta H.
    Eur J Pharmacol; 2010 Aug 10; 639(1-3):99-105. PubMed ID: 20371235
    [Abstract] [Full Text] [Related]

  • 16. Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain?
    Marek GJ, Behl B, Bespalov AY, Gross G, Lee Y, Schoemaker H.
    Mol Pharmacol; 2010 Mar 10; 77(3):317-26. PubMed ID: 19933774
    [Abstract] [Full Text] [Related]

  • 17. The mGlu₅ positive allosteric modulator LSN2463359 differentially modulates motor, instrumental and cognitive effects of NMDA receptor antagonists in the rat.
    Gastambide F, Gilmour G, Robbins TW, Tricklebank MD.
    Neuropharmacology; 2013 Jan 10; 64():240-7. PubMed ID: 22884612
    [Abstract] [Full Text] [Related]

  • 18. Metabotropic glutamate receptors: potential drug targets for the treatment of schizophrenia.
    Chavez-Noriega LE, Schaffhauser H, Campbell UC.
    Curr Drug Targets CNS Neurol Disord; 2002 Jun 10; 1(3):261-81. PubMed ID: 12769619
    [Abstract] [Full Text] [Related]

  • 19. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.
    Goeldner C, Ballard TM, Knoflach F, Wichmann J, Gatti S, Umbricht D.
    Neuropharmacology; 2013 Jan 10; 64():337-46. PubMed ID: 22992331
    [Abstract] [Full Text] [Related]

  • 20. CNS distribution of metabotropic glutamate 2 and 3 receptors: transgenic mice and [³H]LY459477 autoradiography.
    Wright RA, Johnson BG, Zhang C, Salhoff C, Kingston AE, Calligaro DO, Monn JA, Schoepp DD, Marek GJ.
    Neuropharmacology; 2013 Mar 10; 66():89-98. PubMed ID: 22313530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.